Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parameswaran Hari

Showing results (51-60 of 255) with videos related to

Pageof 26
Sort By:
Cytojournal|July 16, 2011
Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: Role of electron microscopy and Congo red stained cell block sectionsSumana Devata, Parameswaran Hari, Natalia Markelova, et al.
Blood Advances|May 15, 2020
Intrathecal chemotherapy for management of steroid-refractory CAR T-cell-associated neurotoxicity syndromeNirav N Shah, Bryon D Johnson, Timothy S Fenske, et al.
Cells|August 27, 2021
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging TherapeuticsHassan Awada, Bicky Thapa, Hussein Awada, et al.
Expert Review of Hematology|December 5, 2018
Adoption of triplet therapy and clinical outcomes in routine practice among newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant in the USAParameswaran Hari, Marlo Blazer, Aditya Raju, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2013
Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantationParameswaran Hari, Todd E DeFor, David H Vesole, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 3, 2009
Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosisRaymond Q Migrino, Ravi K Mareedu, Daniel Eastwood, et al.
Journal of Medical Economics|May 10, 2018
Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myelomaParameswaran Hari, Huamao Mark Lin, Yanyan Zhu, et al.
Blood|August 2, 2021
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapyBinod Dhakal, Sameem Abedin, Timothy Fenske, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2021
KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary MyelomaAseel Alsouqi, Muhammad Khan, Binod Dhakal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 2, 2022
Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myelomaNitya Nathwani, Jill Bell, Dasha Cherepanov, et al.
Pageof 26

Showing results (51-60 of 255) with videos related to

Sort By:
Pageof 26
Cytojournal|July 16, 2011
Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: Role of electron microscopy and Congo red stained cell block sectionsSumana Devata, Parameswaran Hari, Natalia Markelova, et al.
Blood Advances|May 15, 2020
Intrathecal chemotherapy for management of steroid-refractory CAR T-cell-associated neurotoxicity syndromeNirav N Shah, Bryon D Johnson, Timothy S Fenske, et al.
Cells|August 27, 2021
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging TherapeuticsHassan Awada, Bicky Thapa, Hussein Awada, et al.
Expert Review of Hematology|December 5, 2018
Adoption of triplet therapy and clinical outcomes in routine practice among newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant in the USAParameswaran Hari, Marlo Blazer, Aditya Raju, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2013
Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantationParameswaran Hari, Todd E DeFor, David H Vesole, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 3, 2009
Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosisRaymond Q Migrino, Ravi K Mareedu, Daniel Eastwood, et al.
Journal of Medical Economics|May 10, 2018
Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myelomaParameswaran Hari, Huamao Mark Lin, Yanyan Zhu, et al.
Blood|August 2, 2021
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapyBinod Dhakal, Sameem Abedin, Timothy Fenske, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2021
KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary MyelomaAseel Alsouqi, Muhammad Khan, Binod Dhakal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 2, 2022
Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myelomaNitya Nathwani, Jill Bell, Dasha Cherepanov, et al.
Pageof 26